Policy
And Advocacy
To advance our goal of improving the lives of people affected by psoriasis and psoriatic arthritis in Canada, CPN is committed to providing input through government and other relevant consultations on issues that matter to our community. Thank you to everyone who helps to inform our submissions by responding to CPN surveys.
Written Submission to the Pre-Budget Consultations
February 2021. Written Submission to the Pre-Budget Consultations in Advance of the Upcoming Federal Budget 2021 Joint Submission by the Canadian Psoriasis Network and the Canadian Association of Psoriasis Patients
CPN Key Biosimilar Policy Considerations
January 2021
Patented Medicine Prices Review Board (PMPRB)
August 4 2020
Canadian Pain Taskforce Submission
May 29 2020
Home Narrowband Ultraviolet B Phototherapy
November 14 2019